NFAT5 and neoplasm: For instance, degradation of NFAT5 is induced in cardiomyocytes treated with doxorubicin, a commonly used anti-tumor agent, and a concurrent decrease of NFAT5 exacerbates myocyte death upon doxorubicin treatment [16].